The FDA approves a combination of drugs for breast cancer. Source: U.S. Food & Drug Administration. Breast cancer is the second leading cause of death among women.
Re-thinking Chemotherapy.
Source: Medical News Today; Science journal Chemotherapy used to be a very blunt instrument. The chemicals used in chemotherapy were originally developed for destruction of human life of the battlefields of World Wars (ie. Mustard gas). This is once of the reasons why chemotherapy causes injuries to other organs, damaging symptoms such as hair loss, [...]
$1.1 Million Settlement for Delayed Diagnosis of Breast Cancer
Injury: Death from metastatic (spreading) breast cancer. Age of Patient at Injury: 41 years old Result: $1.1 Million Settlement Court: Lehigh County, PA Comment: In this sad case, our client's family doctor did not recommend or refer her patient for surgical consult and biopsy despite presence of a lump. Our client did everything right, including [...]
Radiation Still Common Treatment for Cancer
Source: MD Becker Partners, Life Science Digest; American Cancer Society An estimated 1.1 million patients were treated with radiation in 2009, representing an increase of 15% from 2007 according to a market research study published by IMV Medical Information Division. The clinical application of radiation therapy in oncology (using high-energy radiation to shrink tumors and [...]
Coffee ~the next wonder drug for Cancer?
Source: Journal of the National Cancer Institute, BBC Health Prostate cancer is the most commonly diagnosed male cancer in the USA, and the country's second biggest cancer killer, after lung cancer. 16 million males worldwide are cancer survivors; 2 million are American. A recent publicized study now suggests that men who drink six or more [...]
Tamoxifen Recommended for 5 years
Source: Journal of Clinical Oncology, March 21, 2011 A 10 year follow-up of women aged 50 and over with early breast cancer whose chemotherapy included Tamoxifen has been published in the Journal of Clinical Oncology. The study by researchers at Cancer Research UK touts the benefits of 5 years of Tamoxifen therapy. Tamoxifen or NOLVADEX® [...]
3-D Mammography Approved by US FDA
Source: US Food & Drug Administration Yes, that is quite the attention getter. And no, you can't view it on your home theater system. Mammography is generally felt to be the current best tool for early detection of breast cancer. It is a safe, low-dose X-ray of the breast. The National Cancer Institute recommends women [...]
1 in 8 Women are at Risk for Breast Cancer.
Sources: Cancer Research UK; BBC Health News; American Cancer Society; US National Cancer Institute According to Britain's Cancer Research UK, the risk of a woman developing breast cancer has increased from 1 in 9 to 1 in 8. Breast cancer rates in the UK have increased by 3.5% in 10 years, from 42,400 new cases [...]
Prempro Associated with Breast Cancer.
Source: US Food & Drug Administration Wyeth's Prempro (a hormone replacement drug) was the subject of a Nevada jury verdict (recently upheld by the Supreme Court of Nevada) awarding $57.7 million to 3 women diagnosed with Prempro induced breast cancer. $35 million of that award was in the form of punitive damages for downplaying the [...]
Breast Implants Can Cause Cancer.
Source: US Food & Drug Administration Another "Oops!" from the US FDA. Scientists from the US Government Agency have reached that conclusion after examining scientific literature on cases of ALCL in 34 women with breast implants, as well as information from agency reports, international regulatory agencies, scientific experts, and breast implant manufacturers themselves. The official statement reads: [...]
Gene Blocking to Prevent Breast Cancer Spread?
Sources: BBC Health News; Oncogene Researchers at the University of East Anglia (in Norwich, in the UK) claim to have discovered a gene which may cause cancer cells to move throughout the body. Experiments on tissue cultures (this is all currently in a lab) published in Oncogene, suggest that blocking it would prevent cancers spreading. [...]